Concomitant use of prescription medications and dietary supplements in menopausal women: An approach to provider preparedness

Maturitas

Volumn 68, Issue 3, 2011, Pages 251-255

  Gardiner, Paula ^a   Stargrove, Mitchell Bebel ^b   Low Dog, Tieraona ^c  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b OREGON COLLEGE OF ORIENTAL MEDICINE   (United States)

^c Arizona Center for Integrative Medicine   (United States)

Author keywords

Dietary supplements; Interactions; Menopause

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; CAPTOPRIL; CIMICIFUGA RACEMOSA EXTRACT; CONTRACEPTIVE AGENT; ESTROGEN; FISH OIL; HERBACEOUS AGENT; HORMONE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; TAMOXIFEN; TRAMADOL; VALERIAN; WARFARIN;

BREAST CANCER; CHRONIC DISEASE; CIMICIFUGA RACEMOSA; COUNSELING; CRANBERRY; DIET SUPPLEMENTATION; ESTROGEN THERAPY; GARLIC; GINSENG; HEALTH CARE PERSONNEL; HEART ATRIUM FIBRILLATION; HOT FLUSH; HUMAN; HYPERICUM PERFORATUM; MASTALGIA; MEDICAL DECISION MAKING; MENOPAUSE; OSTEOPOROSIS; POLYPHARMACY; REVIEW; RISK BENEFIT ANALYSIS; SYMPTOM; UNITED STATES;

DIETARY SUPPLEMENTS; DRUG INTERACTIONS; FEMALE; HUMANS; MENOPAUSE; PHYTOTHERAPY; POLYPHARMACY; PRESCRIPTION DRUGS; PROFESSIONAL COMPETENCE; UNITED STATES;

EID: 79951955427     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.11.017     Document Type: Review

References (48)

1. Park K, Harnack L, Jacobs Jr DR. Trends in dietary supplement use in a cohort of postmenopausal women from Iowa. Am J Epidemiol 2009;1169(April (7)):887-92.
2. Gold EB, Bair Y, Zhang G, et al. Cross-sectional analysis of specific complementary and alternative medicine (CAM) use by racial/ethnic group and menopausal status: the Study of Women's Health Across the Nation (SWAN). Menopause 2007;14(July-August (4)):612-23.
3. Gardiner P, Graham RE, Legedza A, Eisenberg DM, Phillips RS. Factors associated with dietary supplement use among prescription medication users. Arch Intern Med 2006;166:1968-74. PMC journal- in process.
4. Van der Sluijs CP, Bensoussan A, Liyanage L, Shah S. Women's health during mid-life survey: the use of complementary and alternative medicine by symptomatic women transitioning through menopause in Sydney. Menopause 2007;14(May-June (3 Pt 1)):397-403.
5. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008;300(December (24)):2867-78.
6. Nahin RL, Pecha M, Welmerink DB, et al. Concomitant use of prescription drugs and dietary supplements in ambulatory elderly people. J Am Geriatr Soc 2009;57(July (7)):1197-205.
7. Cardini F, Lesi G, Lombardo F, van der Sluijs C. The use of complementary and alternative medicine by women experiencing menopausal symptoms in Bologna. BMC Womens Health 2010;10:7.
8. Brett KM, Keenan NL. Complementary and alternative medicine use among midlife women for reasons including menopause in the United States 2002. Menopause 2007;14(March-April (2)):300-7.
9. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States Prevalence, costs, and patterns of use. N Engl J Med 1993;328(January (4)):246-52. (Pubitemid 23035311)
10. Low Dog T. Assessing safety of herbal products for menopausal complaints: an international perspective. Maturitas 2010;66:355-62.
11. Vaysse J, Balayssac S, Gilard V, Desoubdzanne D, Malet-Martino M, Martino R. Analysis of adulterated herbal medicines and dietary supplements marketed for weight loss by DOSY 1H NMR. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2010;27(July (7)):903-16.
12. Miller GM, Stripp R. A study of western pharmaceuticals contained within samples of Chinese herbal/patent medicines collected from New York City's Chinatown. Leg Med (Tokyo) 2007;9(September (5)):258-64.
13. Saper RB, Kales SN, Paquin J, et al. Heavy metal content of ayurvedic herbal medicine products. JAMA 2004;292(December (23)):2868-73. (Pubitemid 39628234)
14. Williams C. Using medications appropriately in older adults. Am Fam Physician 2002;66(10):1917-24. (Pubitemid 36061540)
15. Anantharaju A, Feller A, Chedid A. Aging liver: a review. Gerontology 2002;48(November-December (6)):343-53. (Pubitemid 36152984)
16. Ma J, Drieling R, Stafford RS. US women desire greater professional guidance on hormone and alternative therapies for menopause symptom management. Menopause 2006;13(May-June (3)):506-16.
17. Gurley BJ, Gardner SF, Hubbard MA, et al. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther 2002;72(September (3)):276-87.
18. Hennessy M, Kelleher D, Spiers JP, et al. St Johns wort increases expression of P-glycoprotein: implications for drug interactions. Br J Clin Pharmacol 2002;53(January (1)):75-82. (Pubitemid 34117742)
19. Pfrunder A, Schiesser M, Gerber S, Haschke M, Bitzer J, Drewe J. Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial. Br J Clin Pharmacol 2003;56(December (6)):683-90. (Pubitemid 37491722)
20. Will-Shahab L, Bauer S, Kunter U, Roots I, Brattstrom A. St John's wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive. Eur J Clin Pharmacol 2009;65(March (3)):287-94.
21. Fogle RH, Murphy PA, Westhoff CL, Stanczyk FZ. Does St. John's wort interfere with the antiandrogenic effect of oral contraceptive pills? Contraception 2006;74(September (3)):245-8.
22. Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 2005;77(May (5)):415-26.
23. Wang G, Xiao CQ, Li Z, et al. Effect of soy extract administration on losartan pharmacokinetics in healthy female volunteers. Ann Pharmacother 2009;43(June (6)):1045-9.
24. Li Y, Ross-Viola JS, Shay NF, Moore DD, Ricketts ML. Human CYP3A4 murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner. J Nutr 2009;139(May (5)):898-904.
25. Dunn SP, Bleske B, Dorsch M, Macaulay T, Van Tassell B, Vardeny O. Nutrition and heart failure: impact of drug therapies and management strategies. Nutr Clin Pract 2009;24(February-March (1)):60-75.
26. Stendig-Lindberg G, Tepper R, Leichter I. Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnes Res 1993;6:155-63.
27. Tucker KL. Osteoporosis prevention and nutrition. Curr Osteoporos Rep 2009;7(December (4)):111-7.
28. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293(May (18)):2257-64. (Pubitemid 40629192)
29. Heaney RP, Weaver CM. Calcium vitamin D. Endocrinol Metab Clin North Am 2003;32(March (1)):181-94.
30. Eschiti VS. Lesson from comparison of CAM use by women with female-specific cancers to others: it's time to focus on interaction risks with CAM therapies. Integr Cancer Ther 2007;6(December (4)):313-44. (Pubitemid 350136015)
31. Walji R, Boon H, Guns E, Oneschuk D, Younus J. Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients. Supportive Care Cancer 2007;15(August (8)):913-21.
32. Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001;19(May (10)):2739-45. (Pubitemid 32441380)
33. Rebbeck TR, Troxel AB, Norman S, et al. A retrospective case-control study of the use of hormone-related supplements and association with breast cancer. Int J Cancer 2007;120(April (7)):1523-8. (Pubitemid 46355388)
34. Kamali F, Wynne H. Pharmacogenetics of warfarin. Annu Rev Med 2010;61:63-75.
35. Grady D. Postmenopausal hormone replacement therapy increases risk for venous thromboembolism disease: the heart and estrogen/progestin replacement study. Ann Intern Med 2000;132:689-96. (Pubitemid 30244167)
36. Celestini A, Pulcinelli FM, Pignatelli P, et al. Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets. Haematologica 2002;87(April (4)):420-6. (Pubitemid 34297550)
37. Kim JM, White RH. Effect of vitamin E on the anticoagulant response to warfarin. Am J Cardiol 1996;77(March (7)):545-6. (Pubitemid 26086652)
38. Greenblatt DJ, von Moltke LL, Perloff ES, Luo Y, Harmatz JS, Zinny MA. Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. Clin Pharmacol Ther 2006;79(January (1)):125-33. (Pubitemid 43071237)
39. Bebbington A, Kulkarni R, Roberts P. Ginkgo biloba: persistent bleeding after total hip arthroplasty caused by herbal self-medication. J Arthroplasty 2005;20(January (1)):125-6. (Pubitemid 40127115)
40. Jiang X, Williams KM, Liauw WS, et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2005;59(April (4)):425-32. (Pubitemid 40523886)
41. Jiang X, Williams KM, Liauw WS, et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2004;57(May (5)):592-9. (Pubitemid 38582179)
42. Yuan CS, Wei G, Dey L, et al. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial. Ann Intern Med 2004;141(July (1)):23-7.
43. Bender NK, Kraynak MA, Chiquette E, Linn WD, Clark GM, Bussey HI. Effects of marine fish oils on the anticoagulation status of patients receiving chronic warfarin therapy. J Thromb Thrombolysis 1998;5(July (3)):257-61. (Pubitemid 28241452)
44. Eritsland J, Arnesen H, Gronseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 1996;77(January (1)):31-6. (Pubitemid 26018387)
45. Buckley MS, Goff AD, Knapp WE. Fish oil interaction with warfarin. Ann Pharmacother 2004;38(January (1)):50-2.
46. Corrigan Jr JJ, Marcus FI. Coagulopathy associated with vitamin E ingestion. JAMA 1974;230(December (9)):1300-1.
47. Macan H, Uykimpang R, Alconcel M, et al. Aged garlic extract may be safe for patients on warfarin therapy. J Nutr 2006;136(March (3 Suppl.)):793S-5S.
48. Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother 2000;34(December (12)):1478-82.